论文部分内容阅读
目的:评价131I(131碘)治疗甲状腺功能亢进并发房颤的疗效。方法:对125例甲亢并发房颤患者应用131I治疗后的临床资料进行疗效分析。结果:总有效率97.6%,其中治愈率82.4%,完全缓解9.6%,不完全缓解5.6%,无效2.4%。结论:131I治疗甲亢并发房颤具有简便、安全、疗程短、治愈率高等特点。治疗后虽有一定的甲低发生率,但应用甲状腺激素替代治疗能获得理想的效果。可作为甲亢并发房颤特别是病程较长、年龄较大、症状较重患者治疗的首选方法。
Objective: To evaluate the efficacy of 131I (131I) in the treatment of hyperthyroidism complicated with atrial fibrillation. Methods: The clinical data of 125 patients with hyperthyroidism and atrial fibrillation treated with 131I were analyzed. Results: The total effective rate was 97.6%. The cure rate was 82.4%, the complete remission rate was 9.6%, the partial remission rate was 5.6%, and the effective rate was 2.4%. Conclusion: 131I treatment of hyperthyroidism complicated with atrial fibrillation is simple, safe, short course, high cure rate. Although a certain incidence of hypothyroidism after treatment, but the application of thyroid hormone replacement therapy can achieve the desired effect. Can be used as hyperthyroidism complicated by atrial fibrillation, especially the longer duration, older, symptoms of patients with the preferred method of treatment.